Small-fiber neuropathy in pompe disease: first reported cases and prospective screening of a clinic cohort.

dc.contributor.author

Hobson-Webb, Lisa D

dc.contributor.author

Austin, Stephanie L

dc.contributor.author

Jain, Sneha

dc.contributor.author

Case, Laura E

dc.contributor.author

Greene, Karla

dc.contributor.author

Kishnani, Priya S

dc.coverage.spatial

United States

dc.date.accessioned

2017-08-28T16:25:01Z

dc.date.available

2017-08-28T16:25:01Z

dc.date.issued

2015-04-03

dc.description.abstract

BACKGROUND: Prior autopsy reports demonstrate glycogen deposition in Schwann cells of the peripheral nerves in patients with infantile and late-onset Pompe disease (LOPD), but little is known about associated clinical features. CASE REPORT: Here, we report the first confirmed cases of small-fiber neuropathy (SFN) in LOPD and present the results of a first attempt at screening for SFN in this patient population. After confirming small-fiber neuropathy in 2 LOPD patients, 44 consecutive Pompe patients (iOPD=7, LOPD n=37) presenting to the Duke University Glycogen Storage Disease Program between September 2013 and November 2014 were asked to complete the 21-item Small-Fiber Neuropathy Screening List (SFNSL), where a score of ≥11 is considered to be a positive screen. Fifty percent of patients had a positive SFN screen (mean score 11.6, 95% CI 9.0-14.2). A modest correlation between the SFNSL score and current age was seen (r=0.38, p=0.01), along with a correlation with duration of ERT (r=0.31, p=0.0495). Trends toward correlation with forced vital capacity and age at diagnosis were also present. Women had a higher mean SFNSL score (14.2) than men (8.2, p=0.017). CONCLUSIONS: SFN may occur in association with Pompe disease and precede the diagnosis. Further studies are needed to determine its true prevalence and impact.

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/25835646

dc.identifier

893309

dc.identifier.eissn

1941-5923

dc.identifier.uri

https://hdl.handle.net/10161/15380

dc.language

eng

dc.publisher

International Scientific Information, Inc.

dc.relation.ispartof

Am J Case Rep

dc.relation.isversionof

10.12659/AJCR.893309

dc.subject

Age Factors

dc.subject

Child

dc.subject

Cohort Studies

dc.subject

Erythromelalgia

dc.subject

Female

dc.subject

Glycogen Storage Disease Type II

dc.subject

Humans

dc.subject

Male

dc.subject

Middle Aged

dc.subject

Risk Factors

dc.subject

Sex Factors

dc.subject

Surveys and Questionnaires

dc.subject

Vital Capacity

dc.title

Small-fiber neuropathy in pompe disease: first reported cases and prospective screening of a clinic cohort.

dc.type

Journal article

duke.contributor.orcid

Case, Laura E|0000-0002-2941-2186

duke.contributor.orcid

Kishnani, Priya S|0000-0001-8251-909X

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/25835646

pubs.begin-page

196

pubs.end-page

201

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Neurology

pubs.organisational-group

Neurology, Neuromuscular Disease

pubs.organisational-group

Orthopaedics

pubs.organisational-group

Orthopaedics, Physical Therapy

pubs.organisational-group

Pediatrics

pubs.organisational-group

Pediatrics, Medical Genetics

pubs.organisational-group

School of Medicine

pubs.publication-status

Published online

pubs.volume

16

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Small-fiber neuropathy in pompe disease: first reported cases and prospective screening of a clinic cohort.pdf
Size:
207.13 KB
Format:
Adobe Portable Document Format
Description:
Accepted version